OR WAIT null SECS
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
Here's why psychedelics might be a valuable addition to mental health treatment.
Alexander Somjen discusses the fragmented psychedelic industry, regulatory frameworks, and potential commercial success.
Alexander Somjen is the CEO and Director of Origin Therapeutics.